Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Eton Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +17 vs. Q2 2023
- Shares held
- 6.90M
- +923.4K (+15.5%) vs. Q2 2023
- Total value
- $28.8M
- +$7.91M (+37.9%) vs. Q2 2023
- New holders
- 22
- 10 more added
- Sold out
- 5
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 1 | $4 | 0.00% | +1 | New |
| Lindbrook Capital, LLC | 4 | $17 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 96 | $400 | 0.00% | −748−88.6% | Reduced |
| Wells Fargo & Company | 163 | $680 | 0.00% | +11+7.2% | Added |
| GWM Advisors LLC | 175 | $730 | 0.00% | +175 | New |
| BNP Paribas Arbitrage, SA | 350 | $1.46K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 805 | $3.36K | 0.00% | +805 | New |
| UBS Group AG | 922 | $3.85K | 0.00% | +922 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $4.17K | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 1,000 | $4.17K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,172 | $4.89K | 0.00% | −3,202−73.2% | Reduced |
| Truvestments Capital LLC | 1,848 | $7.71K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4,757 | $19.8K | 0.00% | +4,757 | New |
| Raymond James & Associates | 10,000 | $41.7K | 0.00% | 00.0% | Unchanged |
| Financial Advisors Network, Inc. | 10,633 | $44.3K | 0.01% | +10,633 | New |
| Heron Bay Capital Management | 11,030 | $46.0K | 0.01% | +11,030 | New |
| Quantum Private Wealth, LLC | 11,500 | $48.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,523 | $48.1K | 0.00% | +11,523 | New |
| XTX Topco Ltd | 11,914 | $49.7K | 0.01% | +11,914 | New |
| Charles Schwab Investment Management Inc | 13,239 | $55.2K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 14,672 | $61.2K | 0.00% | +14,672 | New |
| Chicago Trust Co NA | 16,700 | $69.6K | 0.02% | 00.0% | Unchanged |
| Jump Financial, LLC | 21,100 | $88.0K | 0.00% | +21,100 | New |
| Goldman Sachs Group Inc | 25,650 | $107.0K | 0.00% | +25,650 | New |
| Stratos Wealth Partners, LTD. | 26,878 | $112.1K | 0.00% | −31,147−53.7% | Reduced |
| Hillsdale Investment Management Inc. | 28,800 | $120.1K | 0.01% | +28,800 | New |
| Blair William & Co | 36,979 | $154.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,507 | $156.4K | 0.00% | +4,564+13.9% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 38,305 | $159.7K | 0.00% | +38,305 | New |
| Renaissance Technologies LLC | 43,200 | $180.0K | 0.00% | +15,600+56.5% | Added |
| Schonfeld Strategic Advisors LLC | 43,600 | $181.8K | 0.00% | +43,600 | New |
| Squarepoint Ops LLC | 44,642 | $186.2K | 0.00% | +30,609+218.1% | Added |
| Jane Street Group, LLC | 65,210 | $271.9K | 0.00% | +65,210 | New |
| Bank of New York Mellon Corp | 79,402 | $331.1K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 79,552 | $331.7K | 0.00% | +79,552 | New |
| Millennium Management LLC | 80,320 | $334.9K | 0.00% | +80,320 | New |
| State Street Corp | 81,403 | $339.5K | 0.00% | +10,400+14.6% | Added |
| Acadian Asset Management LLC | 97,264 | $403.0K | 0.00% | +97,264 | New |
| Essex Investment Management Co LLC | 110,016 | $458.8K | 0.07% | +43,095+64.4% | Added |
| Parkman Healthcare Partners LLC | 165,000 | $688.0K | 0.13% | +165,000 | New |
| Ameriprise Financial Inc | 186,562 | $778.0K | 0.00% | +186,562 | New |
| Geode Capital Management, LLC | 217,629 | $907.8K | 0.00% | +7,537+3.6% | Added |
| Acuitas Investments, LLC | 219,000 | $913.2K | 0.54% | −291,054−57.1% | Reduced |
| EAM Investors, LLC | 256,623 | $1.07M | 0.21% | +256,623 | New |
| Bridgeway Capital Management, LLC | 271,462 | $1.13M | 0.03% | +30,000+12.4% | Added |
| BlackRock Inc. | 285,176 | $1.19M | 0.00% | −13,049−4.4% | Reduced |
| Paradigm Capital Management Inc | 300,000 | $1.25M | 0.07% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 528,310 | $2.20M | 0.63% | +9,059+1.7% | Added |
| Vanguard Group Inc | 976,436 | $4.07M | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,430,270 | $10.1M | 3.33% | +145,270+6.4% | Added |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −158,676−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5,911−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −5,822−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −4,881−100.0% | Sold out |